# OnCo record tropics-02 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tropics-02/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tropics-02", "NCT03901339" ;
  schema:name "TROPiCS-02"@en ;
  schema:description "The TROP2 ADC extended survival by about three months in heavily pretreated hormone-positive breast cancer."@en ;
  schema:url <https://onco.cc/trials/tropics-02/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03901339> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2019-05-08" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:drugs <https://onco.cc/drugs/sacituzumab-govitecan/> ;
  onco:companies <https://onco.cc/companies/gilead/> ;
  onco:people <https://onco.cc/people/hope-rugo/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-tropics-02-lancet-2023/> .